10-K/A 1 form10ka_12312002.htm AMENDENT NO. 1 10-K Annual Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 10-K/A
(Amendment No. 1)

þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the Fiscal Year Ended December 31, 2002
OR
¨  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934


COMMISSION FILE NUMBER 1-16477

CVTY Logo

COVENTRY HEALTH CARE, INC.
(Exact name of registrant as specified in its charter)

Delaware 52-2073000
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number)

6705 Rockledge Drive, Suite 900, Bethesda, Maryland 20817
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (301)581-0600

Securities registered pursuant to Section 12(b) of the Act:None

Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $.01 par value
Common Stock purchase rights

     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨

     Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ¨

     Indicate by check mark whether the registrant is an accelerated filer (as defined in the Securities Exchange Act of 1934 Rule 12b-2) Yes þ No ¨

     The aggregate market value of the registrant’s voting Common Stock held by non-affiliates of the registrant as of June 30, 2002 (computed by reference to the closing sales price of such stock on the NYSE® stock market on such date) was $1,703,265,252.

     As of February 28, 2003, there were 58,800,208 shares of the registrant’s voting Common Stock outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

     Parts of the registrant’s Proxy Statement for its 2003 Annual Meeting of Shareholders to be filed with the Commission pursuant to Regulation 14A subsequent to the filing of this Form 10-K Report are incorporated by reference in items 10 through 13 of Part III hereof.


EXPLANATORY NOTE

     This Amendment No. 1 is being filed by the Registrant solely to rectify an error made by the Registrant in attaching a draft document as Exhibit 10.17 of the Registrant’s annual report on Form 10-K for the fiscal year ended December 31, 2002 by replacing it with the attached final version of Exhibit 10.17, and does not reflect any events occurring after the date of filing of the original Form 10-K or otherwise modify or update any of the information contained therein.





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


COVENTRY HEALTH CARE, INC.

(Registrant)
Date: October  8 , 2003
By: /s/ Allen F. Wise

Allen F. Wise
President, Chief Executive Officer
and Director





INDEX TO EXHIBITS

Exhibit
No. Description of Exhibit


10.17 2003 Management Incentive Plan
 
31.1 Certification pursuant to Rule 13a-14(a) as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002 made by Allen F. Wise, President, Chief Executive Officer and Director.
 
31.2 Certification pursuant to Rule 13a-14(a) as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002 made by Dale B. Wolf, Executive Vice President, Chief Financial Officer and Treasurer.